Mussi Aparecida Duarte Hg, Pereira Rui Alberto Roldão de Almeida, Corrêa e Silva Vergínia de Azevedo, Martins Regina Maria Bringel, Souto Francisco José Dutra
Laboratório Central de Mato Grosso, Rua Thogo da Silva Pereira, 63, Cuiabá, MT 78020-500, Brazil.
Acta Trop. 2007 Nov-Dec;104(2-3):116-21. doi: 10.1016/j.actatropica.2007.08.001. Epub 2007 Aug 7.
The present study has been carried out to estimate the prevalence of HCV among HIV-positive individuals in the state of Mato Grosso, Central Brazil, as well as to identify the associated epidemiological factors. One thousand and eight individuals over 18 years of age bearing HIV/aids and being attended in the reference public health network of the state of Mato Grosso participated in this research. HIV-positive subjects were interviewed and blood samples were taken to be tested for anti-HCV antibodies by enzyme immunoassay (EIA). The anti-HCV antibodies were investigated in all the individuals by immunoenzymatic assay. The reactive samples in duplicate were submitted to a polymerase chain reaction (PCR) to detect HCV-RNA. The positive tests were submitted for genotyping by the LIA method. One hundred and ten (10.9%; CI 95%: 9.1-13.0) HIV-positive individuals presented anti-HCV by EIA. The PCR was positive in 60 (6.0%; CI 95%: 4.6-7.6) individuals. The 1a genotype was the most frequent, followed by the 3a and 1b. The genotype 2 was found in only one individual. There were more male and intravenous drug users among HIV-HCV coinfected individuals when compared to only HIV-infected individuals. Multivariate analysis revealed an association between the HIV-HCV coinfection, regarding either EIA or PCR results, and the use of intravenous drugs, the presence of tattoos, and having received blood transfusions before 1994. There was no association of the coinfection with the variables related to sexual transmission. The relatively low prevalence of HCV infection in the HIV-positive population in that region may be a consequence of a small number of intravenous drug users in the sample, despite a strong association between HCV infection and use of intravenous drugs.
本研究旨在评估巴西中部马托格罗索州艾滋病毒阳性个体中丙型肝炎病毒(HCV)的流行情况,并确定相关的流行病学因素。1008名18岁以上携带艾滋病毒/艾滋病且在马托格罗索州公共卫生参考网络接受治疗的个体参与了本研究。对艾滋病毒阳性受试者进行了访谈,并采集血样通过酶免疫测定法(EIA)检测抗HCV抗体。通过免疫酶测定法对所有个体进行抗HCV抗体检测。将重复检测呈反应性的样本进行聚合酶链反应(PCR)以检测HCV-RNA。对阳性检测结果采用LIA方法进行基因分型。110名(10.9%;95%置信区间:9.1-13.0)艾滋病毒阳性个体通过EIA检测出抗HCV。60名(6.0%;95%置信区间:4.6-7.6)个体的PCR检测呈阳性。1a基因型最为常见,其次是3a和1b。仅在1名个体中发现了2基因型。与仅感染艾滋病毒的个体相比,艾滋病毒-HCV合并感染个体中男性和静脉吸毒者更多。多变量分析显示,无论EIA还是PCR结果,艾滋病毒-HCV合并感染与静脉吸毒、纹身以及1994年前接受输血之间存在关联。合并感染与性传播相关变量无关联。尽管HCV感染与静脉吸毒之间存在很强的关联,但该地区艾滋病毒阳性人群中HCV感染率相对较低可能是由于样本中静脉吸毒者数量较少。